Caladrius Biosciences, Inc. (LSTA) Tops Q1 EPS by 23c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q1 EPS of ($0.77), $0.23 better than the analyst estimate of ($1.00).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
• TD Cowen Reiterates Buy Rating on NVIDIA (NVDA), 'unlikely to move significantly on earnings'